DIRECTOR DEALINGS: Oxford BioMedica Non-Exec Sells GBP1.8 Million
DIRECTOR DEALINGS: Oxford BioMedica Non-Exec Sells GBP1.8 Million
Read moreDIRECTOR DEALINGS: Oxford BioMedica Non-Exec Sells GBP1.8 Million
Read moreIN BRIEF: Oxford Biomedica Raises GBP40 Million To Fund Investments
Read moreOxford Biomedica Seeks To Raise GBP40 Million Via Share Placing
Read moreOxford Biomedica Says Sanofi To Return Rights To Two Programmes
Read moreUK TRADING UPDATE SUMMARY: Oxford Biomedica Works On Covid-19 Vaccine
Read more* AstraZeneca slips on report of potential merger with Gilead* Plus500 falls after big revenue hit from client trading wins* Oil & gas stocks gain after OPEC production cuts* BP rises after report of job cuts (Adds details, updates to close)By Shr...
Read moreTOP NEWS: Centrica And easyJet Bumped From FTSE 100 For Avast And GVC
Read moreUK EXECUTIVE CHANGE SUMMARY: Rambler Metals & Minerals Picks New CEO
Read more* Lynparza gains CHMP nod for advanced pancreatic cancer* Brilinta approved by FDA to cut risk of first heart attack* Coronavirus vaccine partner Oxford Biomedica appoints new chair (Writes through, adds detail, context)June 1 (Reuters) - Britain's...
Read moreOxford Biomedica Pens Virus Vaccine Supply Deal With AstraZeneca
Read moreUK BROKER RATINGS SUMMARY: Berenberg Raises HSBC To Hold From Sell
Read moreOxford Biomedica Sinks To Loss In 2019 But Remains Optimistic
Read more(Sharecast News) - Gene and cell therapy company Oxford Biomedica reported an improvement in bioprocessing and commercial development revenues to ?47.3m in its preliminary results on Wednesday, from ?40.5m.
Read moreUK Earnings, Trading Statements Calendar - Next 7 Days
Read more(Sharecast News) - Analysts at Liberum hiked their target price on gene and cell therapy company Oxford BioMedica from £8.60 per share to £10.90 on Tuesday, citing demand at its new OxBox manufacturing facility.
Read more